Position in ODTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$15,560,283
New position
Shares Held
831,656
first reported quarter
Ownership
1.73%
of shares outstanding
% of Portfolio
1.87%
of 13F equity value
Holder Rank
#9
of 58 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 100%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026HHLR ADVISORS, LTD. holds $365,309,791 across 9 Biotechnology names. ODTX ranks #3 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LEGN |
Legend Biotech Corp
|
5,984,550 | $172,833,804 | |
| 2 | AVBP |
ArriVent BioPharma, Inc.
|
3,929,117 | $136,497,524 | |
| 3 | ODTX |
Odyssey Therapeutics, Inc.
This page
|
831,656 | $15,560,283 | |
| 4 | NBP |
NovaBridge Biosciences
|
5,980,568 | $11,662,107 | |
| 5 | CTNM |
Contineum Therapeutics, Inc.
|
669,337 | $10,970,433 | |
| 6 | MAZE |
Maze Therapeutics, Inc.
|
366,028 | $10,922,275 | |
| 7 | SGMT |
Sagimet Biosciences Inc.
|
724,800 | $5,602,704 | |
| 8 | GOSS |
Gossamer Bio, Inc.
|
4,974,041 | $820,716 |
All Filings in ODTX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,560,283 | 831,656 | Shares | Other | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||